BMDCMET

Innate and adaptive immune cell contribution to the pre-metastatic niche

 Coordinatore STICHTING HET NEDERLANDS KANKER INSTITUUT 

 Organization address address: PLESMANLAAN 121
city: AMSTERDAM
postcode: 1066 CX

contact info
Titolo: Dr.
Nome: Henri
Cognome: Van Luenen
Email: send email
Telefono: 31205127979

 Nazionalità Coordinatore Netherlands [NL]
 Totale costo 184˙040 €
 EC contributo 184˙040 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2010-IEF
 Funding Scheme MC-IEF
 Anno di inizio 2011
 Periodo (anno-mese-giorno) 2011-06-01   -   2013-05-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    STICHTING HET NEDERLANDS KANKER INSTITUUT

 Organization address address: PLESMANLAAN 121
city: AMSTERDAM
postcode: 1066 CX

contact info
Titolo: Dr.
Nome: Henri
Cognome: Van Luenen
Email: send email
Telefono: 31205127979

NL (AMSTERDAM) coordinator 184˙040.80

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

metastatic    bmdc    cells    niche    bmdcs    determine    disseminated    metastasis    cancer    disease    passive    pre    organs    experimental    populations    breast    event    genetic    tumor    distant    metastases   

 Obiettivo del progetto (Objective)

'Breast cancer metastasis is a foreboding and prevalent disease for women around the world. Over 90% of breast cancer deaths are caused by metastatic disease emphasizing the urgency for more research in this area. While experimental evidence indicates that tumor cells must acquire specific genetic mutations to disseminate and colonize distant organs, these genetic alterations are not sufficient for successful metastasis formation. The microenvironment of metastatic organs must also be pre-conditioned and adapted prior to the arrival of tumor cells. In other words, metastasis is not a passive event – a ‘pre-metastatic niche’ must be established. Bone marrow-derived cells (BMDCs) play a critical role in this process by secreting soluble factors to direct the recruitment of disseminated tumor cells to specific sites. Experimental studies suggest that both innate and adaptive immune cells initiate the pre-metastatic niche, but involvement of particular BMDC populations is largely dependent on tumor type. Together, these data support the hypothesis that breast cancer metastasis is not a passive event, but is regulated by specific BMDC populations in target organs. The overall goal of this application is to examine the cellular and molecular changes that occur in pre-metastatic organs and determine which are crucial for metastasis formation using a novel breast cancer metastasis model developed by the Host laboratory. To assess this, I propose to 1) Perform an in depth kinetic characterization of disseminated tumor cell colonization of distant metastatic organs; and 2) Determine which BMDC population regulates the pre-metastatic niche and their functional significance to metastasis formation. Evaluating the specific role of BMDCs in the initiation of metastases will identify novel targets for breast cancer patients to prevent future metastatic development and/or combat established metastases.'

Altri progetti dello stesso programma (FP7-PEOPLE)

METSGENES (2011)

"Genes, Mediterranean dietary pattern and metabolic syndrome risk"

Read More  

RES GRID INTEGRATION (2012)

Regulated Expansion of Electricity Transmission Networks: the Effects of Fluctuating Demand and RES Generation

Read More  

SMAD1/5 AND CANCER (2009)

A novel mode of TGF-beta signalling through Smad1/Smad5 phosphorylation: mechanism and functional role in cancer

Read More